Aerie Pharmaceuticals misses EPS estimates by 7 cents in Q3
Shares in Aerie Pharmaceuticals (NSDQ:AERI) fell slightly today after the company missed earnings expectations on Wall Street with its third quarter results.
The Irvine, Calif.-based company posted a net loss of -$32.4 million, or -89¢ per share, for the 3 months ended Sept. 30, for bottom-line loss of -36% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Aerie Pharmaceuticals misses EPS estimates by 7 cents in Q3 appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations MassDevice Earnings Roundup Optical/Ophthalmic Pharmaceuticals Wall Street Beat Aerie Pharmaceuticals Source Type: news
More News: Opthalmology | Profits and Losses